Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 1.5B | 1.9B | 1.9B | 1.9B |
Cost of revenue | 766M | 905M | 783M | 807M |
Gross profit | 752M | 991M | 1.1B | 1.1B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 58M | 59M | 42M | 48M |
Other operating expenses | — | — | — | — |
Operating income | 694M | 932M | 1.0B | 1.0B |
Non operating interest income | ||||
Income | 7M | 20M | 6M | 5M |
Expense | 426M | 439M | 430M | 419M |
Other income expense | — | — | — | — |
Pretax income | 217M | 650M | 125M | 1.0B |
Tax provision | 99M | 69M | 164M | 292M |
Net income | 118M | 581M | -39M | 710M |
Basic EPS | 0.6 | 3.0 | -0.2 | 3.8 |
Diluted EPS | 0.6 | 3.0 | -0.2 | 3.8 |
Basic average shares | 194.6M | 194.6M | 183.8M | 183.8M |
Diluted average shares | 194.6M | 194.6M | 183.8M | 183.8M |
EBITDA | 791M | 1.1B | 1.1B | 1.5B |
Net income from continuing op. | 217M | 650M | 125M | 1.0B |
Minority interests | -5M | -2M | -2M | -6M |
Preferred stock dividends | 0 | 0 | 0 | 0 |